Cases 1 - 10 of 301
Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.
as 24-1829
Plaintiff:
ALEXION PHARMACEUTICALS, INC. and ALEXION PHARMA INTERNATIONAL OPERATIONS LTD.
Defendant:
SAMSUNG BIOEPIS CO. LTD.
Astellas Pharma, Inc. v. Lupin Ltd.
as 24-1766
Plaintiff:
ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC., ZYDUS PHARMACEUTICALS (USA) INC. and others
Janssen Pharmaceuticals, Inc. v. Tolmar, Inc.
as 24-1699
Plaintiff:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant:
TOLMAR, INC.
Janssen Pharmaceuticals, Inc. v. Tolmar, Inc.
as 24-1700
Plaintiff:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant:
TOLMAR, INC.
Actelion Pharmaceuticals, Ltd. v. Mylan Pharmaceuticals Inc.
as 24-1641
Plaintiff:
ACTELION PHARMACEUTICALS, LTD.
Defendant:
MYLAN PHARMACEUTICALS INC.
Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited
as 24-1606
Plaintiff:
SUPERNUS PHARMACEUTICALS, INC.
Defendant:
AJANTA PHARMA LIMITED, AJANTA PHARMA USA INC., TORRENT PHARMA INC. and others
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1564
Appellant:
REGENERON PHARMACEUTICALS, INC.
Defendant / Appellee:
MYLAN PHARMACEUTICALS INC. and CELLTRION, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1567
Appellant:
REGENERON PHARMACEUTICALS, INC.
Defendant / Appellee:
MYLAN PHARMACEUTICALS INC., CELLTRION, INC. and SAMSUNG BIOEPIS CO., LTD.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1402
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
